Biogen: Competing With Eli Lilly’s Kisunla, Safety Gives Market Edge (NASDAQ:BIIB)
This article was written byFollowWith over two decades of dedicated experience in investment, Allka Research has been a guiding force...
Lillys
Eli Lilly’s diabetes drug tirzepatide gets approval in China By Reuters
SHANGHAI (Reuters) - Eli Lilly (NYSE:) said on Tuesday its diabetes drug tirzepatide has received approval from Chinese regulators, setting...
